CNS Pharmaceuticals (CNSP) PEG Ratio
Market Cap: $3.09M
Avg Volume: 531.77K
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- CNS Pharmaceuticals's trailing twelve month (TTM) PEG ratio is 0.00.
- CNS Pharmaceuticals's annual PEG ratio as of today is 0.00.
- CNS Pharmaceuticals's quarterly PEG ratio is 0.00.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess CNS Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.15
- Quarterly: -0.18
- TTM: -0.03
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.37
- Quarterly: 0.37
- TTM: 0.06
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.13
- Quarterly: -0.42
- TTM: -0.02
These metrics provide insights into CNS Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
0.00
Annual PEG Ratio
0.00
Quarterly PEG Ratio
0.00
CNS Pharmaceuticals Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
CNS Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 0.00 | -0.15 | 0.00 | 0.37 | -0.13 |
| 2023 | 0.23 | -12.63 | 0.00 | -53.73 | -16.84 |
| 2022 | 312.58 | -10698.48 | 0.00 | 20092.57 | -15477.63 |
| 2021 | 74296.26 | -61783.21 | 0.00 | 135243.81 | -66150.06 |
| 2020 | -1084.42 | -155267.50 | 0.00 | 105284.03 | -200669.09 |
| 2019 | 17622.36 | -837890.30 | 0.00 | 427397.06 | -914226.28 |
| 2018 | -389.93 | -508475.09 | 0.00 | -6842545.39 | -5246615.30 |
| 2017 | 0.00 | -7139255.11 | 0.00 | -64214387.00 | -33499973.26 |
Related Metrics
Explore detailed financial metrics and analysis for CNSP.